BELLUS Health Inc. (BLU) PT Lowered to $6 at Jefferies, After Primary Endpoint Missed In BLU-5937 Trial
Tweet Send to a Friend
Jefferies analyst Suji Jeong lowered the price target on BELLUS Health Inc. (NASDAQ: BLU) to $6.00 (from $20.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
